Figure 6.(A) The immune components between different risk score groups in the CIBERSORT; (B) The immune components between different risk score groups in the XCELL; (C) The different immune components for CIBERSORT and XCELL; (D) The correlation between the T cell CD8+ / B cell plasma and risk score; (E) The KM analysis for the risk score combined with T cell CD8+ / B cell plasma; (F, G) The interaction plots for immune markers and risk score.
